• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Newport Academy Announces Opening of Pacific Northwest Mental Health Treatment Program Led by Executive Director Edward Mosshart, LMHC

Share:

August 19, 2019

Newport Academy, a series of leading adolescent and young adult treatment centers specializing in mental health, trauma, eating disorders, and substance use disorder, recently announced the acquisition of a Washington-based teen and young adult treatment program that is now officially open under the leadership of seasoned behavioral healthcare professional Edward Mosshart, LMHC. Newport Academy Washington State is licensed as a Residential Treatment Facility for Intensive Inpatient and Long-Term Residential Treatment by the Washington State Department of Health and a fully accredited behavioral health facility.

The Washington State program serves adolescent males struggling with mental health and co-occurring issues, including substance use disorder. The residential program joins Newport Academy’s portfolio of high-impact, clinically sophisticated mental health treatment services, bringing young people from self-destruction to self-esteem by treating the underlying causes of high-risk behavior.

“Newport Academy is nationally recognized for empowering minds and restoring families by providing family-focused and results-oriented programs that treat the underlying causes and conditions of destructive behaviors,” said Joe Procopio, Newport Academy’s Chief Executive Officer. “As with our other locations, our Washington site employees create a foundation of compassion and trust to provide a truly unparalleled level of care for individuals and families.”

The new location furthers Newport Academy’s ability to address the national mental health crisis among teens and young adults. Rates of teen depression and suicide have doubled over the last decade, and one in every five teens suffers from an anxiety disorder. Moreover, major depressive episodes (MDEs) have increased by 63 percent for young adults aged 18–25. In Washington State, about 64,000 adolescents have at least one MDE annually, and less than half receive any type of treatment.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Mosshart, a Pacific Northwest native, has been named Executive Director of this Newport Academy location. He spent the last year leading the clinical team at Gray Wolf Ranch after 12 years in private practice in Seattle. He has more than 30 years of experience in the behavioral health field, with a longstanding interest in the intersection between mental and spiritual health and substance dependence. Mosshart has served in a variety of management and administrative positions throughout the course of his career, including six years as clinical director for the largest residential youth treatment center on the West Coast, outpatient clinical director for a private, non-profit medical center, and outpatient clinical director for a treatment program for men and pregnant or parenting women.

“Newport Academy is a leader in mental health treatment for teens and young adults and I am thrilled to join their team,” said Mosshart. “Our clients come to us with complex mental health issues and we help them better understand themselves, develop their personas, and act in accord with their strong and authentic selves, without the negative effects of depression, anxiety and co-occurring disorders. Guiding young men toward a healthier future with sustained recovery is our collective purpose.”

Date: August 19, 2019

Source: Yahoo Finance

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Bold Therapeutics Expands COVID-19 ConsortiumBold Therapeutics Expands COVID-19 Consortium
  • Analysis Group Announces Partnership to Enable Research of Blood Disease in ChinaAnalysis Group Announces Partnership to Enable Research of Blood Disease in China
  • Sonendo® Announces GentleWave® System Integration With TDO® Endodontic SoftwareSonendo® Announces GentleWave® System Integration With TDO® Endodontic Software
  • Blue Shield of CA Taps Cricket Health to Offer AI-Driven, Personalized Kidney Care Plans for Members At No CostBlue Shield of CA Taps Cricket Health to Offer AI-Driven, Personalized Kidney Care Plans for Members At No Cost
  • Validant Acquires Greenleaf Health, Leading FDA Regulatory Consulting FirmValidant Acquires Greenleaf Health, Leading FDA Regulatory Consulting Firm
  • Avera Awarded $4.3M Grant to Establish National Telehealth Certificate ProgramAvera Awarded $4.3M Grant to Establish National Telehealth Certificate Program
  • Hong Kong mobile telemedicine app DrGo adds FibriCheck a-fib screeningHong Kong mobile telemedicine app DrGo adds FibriCheck a-fib screening
  • Rennova Health signs new definitive agreement to acquire Jellico Community Hospital, TennesseeRennova Health signs new definitive agreement to acquire Jellico Community Hospital, Tennessee

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications